<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The diagnosis of <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> can lead to the prevention of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> through periodic colonoscopies and removal of <z:e sem="disease" ids="C0850639" disease_type="Neoplastic Process" abbrv="">premalignant lesions</z:e> in susceptible individuals </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, predisposed individuals identified by mutation analysis are advised to inform their at-risk relatives about the options of predictive DNA testing and preventive measures </plain></SENT>
<SENT sid="2" pm="."><plain>However, it has now been established that more than half of these relatives do not receive the necessary information </plain></SENT>
<SENT sid="3" pm="."><plain>Barriers in conveying information include family communication problems and variable attitudes and practice among clinical geneticists </plain></SENT>
<SENT sid="4" pm="."><plain>In this complex field, both medical, psychological, ethical and juridical aspects deserve consideration </plain></SENT>
<SENT sid="5" pm="."><plain>Here we summarize the development of a revised guideline for clinical geneticists that allows a more active role of the geneticist, aimed at improving procedures to inform family members in <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> and other hereditary and <z:e sem="disease" ids="C1333600" disease_type="Neoplastic Process" abbrv="">familial cancer</z:e> syndromes </plain></SENT>
</text></document>